Bupivacaine study launches!
Updated: Mar 14, 2021
The Bupivacaine study has officially launched! The first two participants will take part in the study this upcoming week.
Congratulations to the entire team for the hard work they have put into getting this study ready, and all the best for the next two years on this project! Anja Frost, MD, PG Y4 in the Gynecology & Obstetrics Residency Program at Johns Hopkins, is the lead investigator on this study. Karen Wang, MD, Fellowship Director of the Minimally Invasive Gynecologic Surgery (MIGS) program, is the principal investigator on the study, and Obianuju Okonkwo, BS, serves as the primary study coordinator.